Webinar
Healthtech and the Future of Digital Health
Chris Coburn, Chief Innovation Officer at Mass General Brigham, joined us for an exclusive event to help define digital health and explore the trends shaping the industry. This special event was cohosted by Lacey Johnson, Managing Partner of Alumni Ventures’ Healthtech Fund and Senior Partner* Charles Patrick. Watch a short highlight of our conversation below.
The rapid evolution of developing technologies like AI and machine learning, blockchain, 3D printing, gene technology, nanotechnology, computers, smartphones, and software are enabling advances in healthtech. Driven in part by the Covid-19 pandemic, now more than ever people are leaning towards proactive and preventative care for the mind, body, and behavior, demanding more convenience and flexibility.
The investment opportunity in healtech and digital health is equally exciting. Some sources gauge the digital health global market size at approximately $350 billion in 2019, reaching $950 billion by 2027. There are around 20,000 healthtech startups in the U.S., and venture capital firms invested about $14 billion into the sector in 2020 — double 2019’s total. But what is digital health, and why is it important?
*A registered representative of Independent Brokerage Solutions LLC MEMBER: FINRA / SIPC 485 Madison Ave 15th Fl New York, NY 10022 t-212-751-4424 (“IndieBrokers”). Brokered securities activities and other broker-dealer services offered by Alumni Ventures associated personnel are conducted in their capacities as registered representatives of IndieBrokers. Alumni Ventures, its affiliates and other related parties, and IndieBrokers are independent, unaffiliated entities. To check the background of IndieBrokers and its representatives, visit FINRA’s BrokerCheck. Please see important disclosure information on our Form CRS.
Healthtech Fund Open Through Q2 2022
Our Healthtech Fund will invest in a diversified portfolio of ~20-30 companies applying secure record digitization, telemedicine, big data, genomics, and real-time monitoring via wearable devices. The fund will be invested over ~12-18 months, with a large reserve (~20-25%) for follow-ons. Every investor becomes a member of the Healthtech Venture Club, with opportunities to invest in Syndications, learn, and network.
Click below to review fund materials or connect with a Senior Partner.
About your presenters
Chief Innovation Officer | Mass General Brigham
Chris Coburn is Chief Innovation Officer at Mass General Brigham, an integrated health care system and the nation’s largest academic research enterprise with over $16 billion in annual revenue, 1.5 million patient visits and more than $2 billion in research expenditures. Mr. Coburn leads a team of more than 140 tasked with the worldwide commercial application of the unique capabilities and discoveries of Mass General Brigham’s 85,000 employees. His unit’s business development responsibilities include investing, company creation, innovation management, industry collaborations, and licensing. From this work, more than 300 companies have been spun-off from Mass General Brigham in the last decade and large-scale industry collaborations have been established in areas such as AI and drug development.
Lacey is director of investments on the investment team at Grinnell College, a nationally top-ranked liberal arts college. She was previously a Managing Partner at Green D, where she was responsible for investment due diligence and sourcing, with a focus on digital health, enterprise software, and impact investing. Prior to that, Lacey was an investment associate at CareGroup Investment Office, an associate at J.P. Morgan Asset Management, and an analyst in the Securities Division of Goldman Sachs. She earned a bachelor’s in history from Middlebury College and an MBA from Tuck. Lacey was cited by Chief Investment Officer Magazine for its “40 under 40” recognition.
Senior Partner | (Moderator)
Charles is an experienced financial services leader with deep expertise in equity markets and wealth management. Prior to joining Alumni Ventures, he was Head of Equity Capital Markets within the Merrill Lynch Investor Solutions Group at Bank of America. In this role he oversaw marketing, distribution, and allocation of IPOs and capital markets solutions and was a trusted partner to some of the firm’s biggest financial advisors. Prior to Merrill, Charles held various sales and management roles at Mosher Financial, where he focused on employee benefits in the education and non-profit markets and led a strategic initiative to provide retirement benefits to San Francisco, Oakland, and San Jose Charter Schools. Charles received a B.A. in Economics from the University of California, Berkeley, and attained an MBA in Finance and Entrepreneurship at NYU Stern School of Business. A native of Southern California, Charles serves on the small business board of Upper Manhattan Empowerment Zone (UMEZ), aimed at startup/growth business formation and job creation. He is former co-chair of the emerging leaders board of Enterprise New York, a leader in providing innovative affordable housing solutions to local communities. Charles is an alumni of Management Leadership for Tomorrow (MLT) and Executive Leadership Council (ELC) fellow.